ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
Avatar

EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM

By ecancer FEATURING Claudio Cerchione
By ecancer FEATURING Claudio Cerchione
92 views
September 2, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Myeloma
08:50

New

Isa-KRd in NDMM: Takeaways From the MIDAS & CONCEPT Studies

ecancer

P. Moreau

8 views
06:02

New

Frailty Subanalysis of IMROZ: Isatuximab + RVD for Transplant-Inelig…

ecancer

S. Manier

10 views
06:12

Idecabtagene Vicleucel for R/R MM: Updated Results From the KarMMa T…

ecancer

L. Anderson

60 views
07:41

Efficacy and Safety Data for Ciltacabtagene Autoleucel in Progressiv…

ecancer

A. Cohen

126 views
05:51

Melflufen and Dexamethasone vs. Pomalidomide and Dexamethasone in R/…

ecancer

F. Schjesvold

50 views
06:50

EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM

ecancer

C. Cerchione

92 views
07:49

EHA 2021 Update on Carfilzomib Non-refractory MM: Surveying Efficacy…

ecancer

C. Gasparetto

66 views
05:49

EHA 2021 Update on D-Rd vs. Rd in Transplant-Ineligible Newly Diagno…

ecancer

T. Facon

19 views
28:47

ASH Updates on IO in R/R MM: Which Agents Are Available and How to C…

ecancer

R. Rifkin, S. Lonial, E. Smith, E. Terpos, N. Shah

122 views
06:59

ESMO Guidelines on Bone Health in Cancer: What Is the Agent of Choic…

ecancer

R. Coleman

11 views
20:31

ASH 2020 MM Expert Discussion: What Does IKEMA, ICARIA-MM & APOLLO D…

ecancer

M. Mateos, M. Dimopolous, S. Kumar, M. Beksaç

367 views